These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. A descriptive analysis of medicines safety advisories issued by national medicines regulators in Australia, Canada, the United Kingdom and the United States - 2007 to 2016. Perry LT; Bhasale A; Fabbri A; Lexchin J; Puil L; Joarder M; Mintzes B Pharmacoepidemiol Drug Saf; 2020 Sep; 29(9):1054-1063. PubMed ID: 32696556 [TBL] [Abstract][Full Text] [Related]
13. Safety update: febuxostat and CVD. Drug Ther Bull; 2023 Jul; 61(7):102. PubMed ID: 37321803 [No Abstract] [Full Text] [Related]
14. Development of a novel regulatory pharmacovigilance prioritisation system: an evaluation of its performance at the UK Medicines and Healthcare products Regulatory Agency. Seabroke S; Wise L; Waller P Drug Saf; 2013 Oct; 36(10):1025-32. PubMed ID: 23821159 [TBL] [Abstract][Full Text] [Related]
15. Safety update: metformin and vitamin B Drug Ther Bull; 2022 Sep; 60(9):131. PubMed ID: 35902109 [No Abstract] [Full Text] [Related]
16. [Direct reporting by patients of adverse drug reactions in Spain]. Esther Salgueiro M; Jimeno FJ; Aguirre C; García M; Ordóñez L; Manso G Farm Hosp; 2013; 37(1):65-71. PubMed ID: 23461502 [TBL] [Abstract][Full Text] [Related]
17. Adverse consequences of low-dose methotrexate medication errors: data from French poison control and pharmacovigilance centers. Vial T; Patat AM; Boels D; Castellan D; Villa A; Theophile H; Torrents R; Kassai B Joint Bone Spine; 2019 May; 86(3):351-355. PubMed ID: 30243781 [TBL] [Abstract][Full Text] [Related]
18. New safety measures for isotretinoin. Drug Ther Bull; 2023 Jul; 61(7):99. PubMed ID: 37225394 [No Abstract] [Full Text] [Related]
19. Safety update on home use of nebulisers for acute asthma treatment in children. Drug Ther Bull; 2022 Dec; 60(12):180. PubMed ID: 36261275 [No Abstract] [Full Text] [Related]
20. Sustained Decline of Direct General Practitioner Reporting of Adverse Drug Reactions in Australia and Paucity in Details of Australian Reports in Safety Advisories. Boyd IW; McEwen J Drug Saf; 2023 Jul; 46(7):703-710. PubMed ID: 37266905 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]